CHD5 Antibody

中文名稱：

CHD5兔多克隆抗體
貨號：

CSB-PA848409LA01HU
規(guī)格：

￥440
圖片：
Immunohistochemistry of paraffin-embedded human liver cancer using CSB-PA848409LA01HU at dilution of 1:100

Immunohistochemistry of paraffin-embedded human placenta tissue using CSB-PA848409LA01HU at dilution of 1:100

Immunofluorescent analysis of Hela cells using CSB-PA848409LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) CHD5 Polyclonal antibody
Uniprot No.：

Q8TDI0
基因名：

CHD5
別名：

ATP-dependent helicase CHD5 antibody; CHD 5 antibody; CHD-5 antibody; CHD5 antibody; CHD5_HUMAN antibody; Chromodomain-helicase-DNA-binding protein 5 antibody; DKFZp434N231 antibody; KIAA0444 antibody; RP1-233K16.2 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Chromodomain-helicase-DNA-binding protein 5 protein (1600-1699AA)
免疫原種屬：

Homo sapiens (Human)

標記方式：

Non-conjugated

本頁面中的產品，CHD5 Antibody (CSB-PA848409LA01HU)，的標記方式是Non-conjugated。對于CHD5 Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產品名稱	應用
HRP	CSB-PA848409LB01HU	CHD5 Antibody, HRP conjugated	ELISA
FITC	CSB-PA848409LC01HU	CHD5 Antibody, FITC conjugated
Biotin	CSB-PA848409LD01HU	CHD5 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, IHC, IF

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200
IF	1:50-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
Immunofluorescence (IF) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Chromatin-remodeling protein that binds DNA through histones and regulates gene transcription. May specifically recognize and bind trimethylated 'Lys-27' (H3K27me3) and non-methylated 'Lys-4' of histone H3. Plays a role in the development of the nervous system by activating the expression of genes promoting neuron terminal differentiation. In parallel, it may also positively regulate the trimethylation of histone H3 at 'Lys-27' thereby specifically repressing genes that promote the differentiation into non-neuronal cell lineages. Tumor suppressor, it regulates the expression of genes involved in cell proliferation and differentiation. Downstream activated genes may include CDKN2A that positively regulates the p53/TP53 pathway, which in turn, prevents cell proliferation. In spermatogenesis, it probably regulates histone hyperacetylation and the replacement of histones by transition proteins in chromatin, a crucial step in the condensation of spermatid chromatin and the production of functional spermatozoa.
基因功能參考文獻：
1. CHD5 was identified as a direct target of miR-454. CHD5 was downregulated in GC tissues/cell lines and the expresssion of CHD5 inversely correlated with the level of miR-454 in GC tissues. Taken together, these observations indicate that HDAC3 is associated with GC cell growth via the miR-454-mediated targeting of CHD5. PMID: 29115379
2. Data show that chromodomain helicase DNA binding protein 5 (CHD5) acted as a functional tumor suppressor and was frequently silenced by promoter CpG methylation in renal cell carcinoma (RCC). PMID: 26943038
3. CHD5 may act as a tumor suppressor gene in NSCLC. PMID: 28400267
4. Authors identified the CHD5 as a direct target of miR-454. CHD5 was downregulated in HCC tissues and cell lines and the expression level of CHD5 was inversely correlated with the expression of miR-454 in HCC tissues. PMID: 26287602
5. Data show a mutual suppression regulation between chromodomain helicase DNA binding protein 5 (CHD5) and enhancer of zeste homolog 2 (EZH2, which may provide new insights into their potential therapeutic significance for hepatocellular carcinoma (HCC). PMID: 26517514
6. CHD5 methylation of rectal cancer has a great effect in influencing its clinical and pathological features. PMID: 26753653
7. Study shows that CHD5 is a Nucleosome remodeling and deacetylase complex-associated transcriptional repressor and identifies WEE1 as one of the CHD5-regulated genes that may link CHD5 to tumor suppression. PMID: 25247294
8. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. PMID: 24276239
9. CHD5 is a potential tumour suppressor gene epigenetically silenced in hepatocellular carcinoma. PMID: 24529164
10. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping. PMID: 24923445
11. repression of CHD5 gene expression in human leukemia is mediated in part by DNA methylation of its promoter. PMID: 24454811
12. CHD5 activity is regulated by DNA methylation and repressive histone modifications. CHD5 likely acts as a tumor-suppressor gene in early colorectal carcinogenesis. PMID: 24243398
13. CHD5 might act as a tumor suppressor in glioma PMID: 23707602
14. These findings provide insights into the regulatory role of CHD5 during neurogenesis and suggest how inactivation of this candidate tumor suppressor might contribute to neuroblastoma. PMID: 23948251
15. Decreased expression of chromodomain helicase DNA-binding protein 5 is associated with primary gallbladder carcinoma PMID: 22855185
16. CHD% protein mediates the p53-dependent senescence program triggered by decreased JMJD2A levels. PMID: 23168260
17. study concludes that down-regulation of CHD5, mediated at least in part by promoter methylation, contributes to the development and progression of human breast cancer PMID: 22569290
18. In this Caucasian population, endometriosis seems to be associated with the tumor-suppressor gene CHD5. Our findings support recent data, suggesting that the 1p36 region plays an important role in endometrios. PMID: 22910690
19. CHD5 is a potential tumor suppressor gene that is inactivated via an epigenetic mechanism in lung cancer. PMID: 22186629
20. Studies identified three genes, CHD5, PAFAH1B1, and NME1, strongly associated with patient outcome. PMID: 22328561
21. We conclude that (i) somatically acquired CHD5 mutations are rare in primary NBs, so inactivation probably occurs by deletion and epigenetic silencing. PMID: 22294723
22. the association of between miR-211-regulated CHD5 expression and CHD5 function in colorectal tumorigenesis PMID: 22235338
23. CHD5 is downregulated in a certain number of ovarian cancers and appears to be an adverse predictor candidate of ovarian cancer disease-free and total survival. PMID: 21860208
24. data suggest that CHD5 is a tumor suppressor gene that is epigenetically downregulated in laryngeal squamous cell carcinoma. PMID: 21636313
25. As only one of the 47 families studied has the CHD5 rs7513548 SNP variant, it appears to be a rare event and further screening of melanoma families is required to confirm whether or not CHD5 is involved in melanoma pathogenesis. PMID: 21250965
26. Data show a strong association of CHD5 expression with favorable prognostic variables (age at diagnosis <12 months, low clinical stage, and favorable histology), overall survival and event-free survival. PMID: 20950435
27. CHD5 is a tumor suppressor gene epigenetically down-regulated in gastric cancer PMID: 19840376
28. CDH5 may play a role in the development of the nervous system, and it may also play a role in the pathogenesis of neural tumors. PMID: 12592387
29. Study demonstrates that Chd5 functions as a tumor suppressor in vivo and implicates deletion of CHD5 in human cancer. PMID: 17289567
30. A recent functional study identified chromodomain helicase DNA-binding protein 5 (CHD5) as a novel tumor suppressor mapping to 1p36. [REVIEW] PMID: 18413720
31. CHD5 is the strongest candidate tumor suppressor gene that is deleted from 1p36.31 in neuroblastomas, and inactivation of the second allele may occur by an epigenetic mechanism. PMID: 18577749
32. the DNA methylation profiles of CHD family members (CHD1-9) in different tumor types. PMID: 18698156
33. study demonstrated the existence of somatic mutations and methylation of CHD5 in primary epithelial ovarian cancers; CHD5 may play a role as a tumor suppressor gene in ovarian cancer PMID: 18953434
顯示更多

收起更多
相關疾病：

Defects in CHD5 may be a cause of the development of cancers from epithelial, neural and hematopoietic origin. CHD5 is one of the missing genes in the del(1p36), a deletion which is extremely common in this type of cancers. A decrease of its expression, results in increased susceptibility of cells to Ras-mediated transformation in vitro and in vivo (PubMed:17289567).
亞細胞定位：

Nucleus.
蛋白家族：

SNF2/RAD54 helicase family
組織特異性：

Preferentially expressed in total brain, fetal brain, and cerebellum. It is also moderately expressed in the adrenal gland and detected in testis.
數據庫鏈接：

HGNC: 16816

OMIM: 610771

KEGG: hsa:26038

STRING: 9606.ENSP00000262450

UniGene: Hs.522898

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human